The landscape of dementia diagnosis has advanced dramatically with the appearance of subtle biomarkers, which include amyloid PET scans, tau imaging, and blood-based mostly assessments that may detect Alzheimer's pathology decades in advance of symptoms emerge. When these technological improvements represent impressive development in understanding